ARCHIVES

Orphan Designation Granted To Advaxis HPV Immunotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

Includes May issue of Business & Regulatory Report.

May 31, 2002

Abeloff Plans To Step Down As Cancer Center Director at Hopkins.

November 10, 2006

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981